Related by context. Frequent words. (Click for all words.) 65 erythropoiesis stimulating agent 62 Dasatinib 62 Anticoagulation 62 Drug Candidate 61 Bevacizumab 61 Pediatric Patients 61 Study Demonstrates 61 Phase III Clinical Trial 60 Denufosol 60 Chronic Heart Failure 60 Preclinical Data 60 Antihypertensive 59 Clinical Trial Results 59 Pulmonary Arterial Hypertension 59 Allergic Rhinitis 59 RNAi Therapeutics 59 Recombinant Human 58 Low Dose 58 Solid Tumors 58 Antipsychotic 58 Anti TNF 58 Eculizumab 58 Meta Analysis 58 Small Molecule 58 Regimens 57 relapsing multiple sclerosis 57 Pivotal Trial 57 Surgical Treatment 57 Prostate Cancer Treatment 57 Analogs 57 Tacrolimus 57 Insulin Resistance 57 Patient Registry 57 Aliskiren 57 Autoimmune Diseases 57 Acute Myocardial Infarction 56 Patient Outcomes 56 Hepatic 56 Etanercept 56 Inhibits 56 Atopic Dermatitis 56 Acute Coronary Syndromes 56 Pharmacological 56 Metastatic Colorectal Cancer 56 Venous Thromboembolism 56 Targeted Therapy 56 Immunogenicity 55 FDA Accepts 55 Bioavailability 55 Rheumatoid Arthritis RA 55 Anti Inflammatory 55 Breast Cancer Treatment 55 Early Diagnosis 55 Amrubicin 55 Alemtuzumab 55 Post Operative 54 Autoimmune Disease 54 Oxaliplatin 54 Anticancer 54 orphan medicinal product 54 Chronic Lymphocytic Leukemia 54 Pivotal Phase III 54 sunitinib malate 54 Myocardial 54 Patient Enrollment 54 Clinical Outcomes 54 Recommended Practices 54 Percutaneous Coronary Intervention 54 Gastric Cancer 54 liposomal formulation 54 Methylphenidate 54 Pharmacokinetic 54 Orphan Drug status 54 Carotid 54 HSCT 53 vismodegib 53 Cancer Therapies 53 Study Examines 53 Patent Covering 53 Carfilzomib 53 Increases Risk 53 multiple myeloma MM 53 FDA Orphan Drug 53 Biosimilar 53 Preterm Birth 53 Multicenter 53 Cardiac Imaging 53 Orphan Medicinal Product 53 CCX# 53 neovascular age 53 Clofarabine 53 Systematic Review 53 Monoclonal Antibody 53 Positive Opinion 53 Blood Glucose 52 Phase Ib II 52 Cancer Vaccines 52 Natural Catastrophe Stress 52 Monoclonal Antibodies 52 pharmacokinetic PK 52 Marketing Authorisation